Horizontal Ridge Augmentation Using Polyvinylidene Fluoride Versus Titanium Mesh Membranes (NCT07095530) | Clinical Trial Compass
CompletedNot Applicable
Horizontal Ridge Augmentation Using Polyvinylidene Fluoride Versus Titanium Mesh Membranes
Egypt42 participantsStarted 2024-06-01
Plain-language summary
This study aims to evaluate the effectiveness of a new PVDF non-resorbable membrane versus Titanium Mesh in the treatment of horizontal ridge defects prepared for implant placement
Who can participate
Age range18 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All patients were diagnosed with Class I (Horizontal ridge deficiency) according to Seibert's classification of alveolar ridge deficiencies (Seibert, 1983) .Maxilla and mandible partial edentulism, not more than 2 teeth missing with D3, D4 bone density(Smith \& Zarb, 1989).
* Presence of a horizontally deficient edentulous ridge (Low \< 5 mm) (Misch et al., 2021).
* Good systemic health (ASA I ) (Böhmer et al., 2021).
* Patients aged 18-55 years.
* Non-smokers or light smokers (\<10 cigarettes/day).
Exclusion Criteria:
* Poor oral hygiene with BOP \> 20%.
* Heavy smoking (more than 10 cigarettes per day).
* local and systemic acute infection.
* Patients who received radiotherapy in the head and neck within the previous five years.